Myraquat
Industrielaan 12
9800 Deinze
BE
Myraquat
Foundation date
14/04/2020
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
Myraquat develops therapeutic compounds acting as membrane modulators to control pathogenic microorganisms.
Upcoming events
All events-
0712 '22
Emerging Applications of Microbes (2nd edition)
Event by: VIB -
1212 '22
Type 2 Immunity in Homeostasis and Disease (2nd edition)
Event by: VIB -
2911 '22
BioFIT 2022
Event by: Eurasanté
Latest news
More news-
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
1 day ago
Read more
-
Indigo Diabetes announces first participant enrolled in the SHINE clinical trial
Thursday September 29th 2022
Read more
-
FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome
Tuesday September 27th 2022
Read more
Jobs
More jobs-
05/10/22
Flemish Brabant
Postdoctoral Researcher to study potassium channel Kv1.3 in Parkinson’s disease
Permanent
VIB -
05/10/22
Flemish Brabant
Postdoctoral Fellow for Laboratory of Interneuron Developmental Dynamics
Permanent
VIB -